Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, secures a spot on Fortune's 2025 list of the 100 Most ...

Atlassian announces a multi-year partnership with Google Cloud to strengthen AI capabilities and accelerate cloud ...

Home appliance brand Nuuk has raised over USD 2 million (around INR 19 crore) in a follow-on funding round led by Vertex ...

NEW YORK, NY-Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, has been named one of the 100 Most Powerful ...

Vertex, Inc. (NASDAQ: VERX) reported solid top-line growth for the second quarter of 2025, driven by rising demand for ...

Kolkata, Aug 7 (PTI) India must focus on building scalable, inclusive, and monetisable AI applications tailored for the next ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $41.83, a high estimate of $50.00, and a low estimate of $30.00. This current ...

Following these transactions, Kewalramani directly owns 115,968 shares of Vertex Pharmaceuticals. Based on InvestingPro analysis, the stock currently trades below its Fair Value, with analysts setting ...

Nimblemind.ai – a healthcare startup in Chicago dedicated to offering a faster and safer way to structure, label, and manage ...

The RMR Group (Nasdaq: RMR) today announced on behalf of its managed joint venture that it has facilitated a $1.0 billion five-year, interest-only fixed rate mortgage financing with a weighted-average ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

ANZ Banking Group is to pilot a generative AI-powered upgrade of its Economic Pulse insights platform to help institutional ...